help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 11, 2007, doi:10.1164/rccm.200602-301OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200602-301OCv1
177/4/426    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Möller, W.
Right arrow Articles by Kreyling, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Möller, W.
Right arrow Articles by Kreyling, W. G.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 426-432, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200602-301OC


Original Article

Deposition, Retention, and Translocation of Ultrafine Particles from the Central Airways and Lung Periphery

Winfried Möller1, Kathrin Felten1, Knut Sommerer2, Gerhard Scheuch2, Gabriele Meyer3, Peter Meyer1, Karl Häussinger3 and Wolfgang G. Kreyling1

1 Inflammatory Lung Diseases Clinical Cooperation Group, Institute for Inhalation Biology, and Aerosols and Health Focus Network, GSF-National Research Center for Environment and Health, Gauting and Neuherberg, Germany; 2 Inamed Research GmbH, Gauting, Germany; and 3 Asklepios Hospital for Respiratory Diseases, Gauting, Germany

Correspondence and requests for reprints should be addressed to Dr. Winfried Möller, Ph.D., GSF–National Research Center for Environment and Health Institute for Inhalation Biology, Robert Koch Allee 29, D-82131 Gauting, Germany. E-mail: moeller{at}gsf.de

Rationale: Little is known about clearance of ultrafine carbon particles from the different regions of the human lung. These particles may accumulate and present a health hazard because of their high surface area.

Objectives: Technetium Tc 99m (99mTc)–radiolabeled 100-nm-diameter carbon particles were inhaled by healthy nonsmokers, asymptomatic smokers, and by patients with chronic obstructive pulmonary disease (COPD).

Methods: Using a bolus inhalation technique, particle deposition was targeted either to the airways or to the lung periphery, and retention, clearance, and translocation were measured using retained radiotracer imaging.

Measurements and Main Results: In vitro studies revealed that mean leaching of soluble 99mTc-radiotracer from the carbon particles was 4.1 (2.6 [SD]) % after 24 hours. Cumulative 99mTc activity in urine at 24 hours was 1.1 (1.3) % of activity deposited in the lungs. In the lung periphery, particle retention was not affected by smoking or pulmonary disease; retention was 96 (3) % after 24 hours. The small amount of clearance could be attributed to leaching of the 99mTc label, suggesting negligible particle clearance. In healthy nonsmokers, retention of particles targeted to the airways was 89 (6) and 75 (10) % after 1.5 and 24 hours, respectively. Radiolabel activity did not accumulate in the liver.

Conclusions: Within the limits of detection of our experimental system, most inhaled ultrafine carbon particles are retained in the lung periphery and in the conducting airways without substantial systemic translocation or accumulation in the liver at 48 hours. Repeated exposure may result in significant pulmonary accumulation of ultrafine particles.

Key Words: air pollution • clearance • translocation • ultrafine particles


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
It has been suggested that ultrafine particles may play a key role in the morbidity and mortality of inhaled air pollution. The fate of inhaled ultrafine particles in the different regions of the human lung is unclear and systemic translocation to other organs, such as the liver or the heart, is under debate.

What This Study Adds to the Field
Inhaled ultrafine carbon particles are retained long term in the human lung and may accumulate. Mucociliary clearance does not remove all particles deposited in the airways and is impaired in smokers and in patients with chronic obstructive pulmonary disease. Our study does not show significant systemic translocation.

 

Related articles in AJRCCM:

Reducing Exposure to Airborne Particles: A Novel Strategy to Improve Cardiovascular Health
Nicholas L. Mills, Günter Oberdörster, and David E. Newby
AJRCCM 2008 177: 366-367. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. L. Mills, G. Oberdorster, and D. E. Newby
Reducing Exposure to Airborne Particles: A Novel Strategy to Improve Cardiovascular Health
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 366 - 367.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society